FY26 HCD-W Coagulation Analyzer CPRR Consolidation Effort
Defense Health Agency · DEFENSE HEALTH AGENCY HCD WEST
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation HT941026Q2004 in this department, oldest first.
- Mar 24, 2026SolicitationOpen
- Apr 23, 2026SolicitationOpen
- Apr 30, 2026SolicitationOpen
- May 19, 2026Combined Synopsis/SolicitationOpen
- May 20, 2026Combined Synopsis/SolicitationOpen
- Jun 1, 2026Combined Synopsis/SolicitationOpen
- Jun 3, 2026Combined Synopsis/SolicitationOpen
- Jun 3, 2026Combined Synopsis/SolicitationOpen
- Jun 16, 2026Combined Synopsis/SolicitationOpen
- Jun 23, 2026Combined Synopsis/SolicitationOpen
- Jun 24, 2026Combined Synopsis/SolicitationOpen
- Jun 26, 2026Combined Synopsis/SolicitationOpen
- Sep 10, 2026Combined Synopsis/SolicitationOpen
- Sep 10, 2026Combined Synopsis/SolicitationOpen
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Read the notice on SAM.gov for what is being asked.
What the notice says
The requirement is for a Cost Per Reportable Result (CPRR) contract for Coagulation analyzers to support the military treatment facilities (MTFs) and their workloads across HCD-W. The analyzers shall be provided under a cost-per-reportable-result (CPRR) agreement that includes all reagents, controls, supplies, consumables, coagulation analyzer equipment, parts, peripherals, and accessories, as well as all services necessary for coagulation analysis/testing, preventive maintenance, and repairs. The analyzers will be utilized for performing coagulation testing. The CPRR price shall include: One … (show all)
(1) base year and four (4) option years. All reagents, standards, quality controls, supplies, consumable/disposable items, parts, accessories and any other item required for the proper operation of the Contractor�s equipment and necessary for the generation of a reportable result. This per reportable result price shall also encompass all costs associated with dilution; repeat and confirmatory testing required producing a single patient reportable result. It shall also include the material to perform as well as all other costs associated with quality control (QC), calibration and correlation study testing that is prescribed by the Clinical Laboratory Standards Institute (CLSI); All necessary maintenance to keep the equipment in good operating condition. This element includes both preventive maintenance and repairs; Training for Government personnel to include user-level training of core staff (up to 10 users on day and evening time frame), super-user level advanced training sessions (2 upon installation and 1 per instrument installed, per contract option year thereafter). Travel and lodging will be at the expense of the Contractor for super-user training conducted at Contractor training location; Delivery, installation and removal of laboratory analyzers; and Peripheral equipment such as printers, Uninterrupted Power Supply (UPS) units (minimum of 1-hour capability), and all parts required to operate in accordance with proposed capabilities.
Who won similar work
3 award notices on SAM.gov in the last 24 months. Matched by: Same office (DEFENSE HEALTH AGENCY HCD WEST), same product/service code (PSC) 6550 and NAICS 334516.
Single-winner award sizes (3): middle half $1.4M to $3.7M, median $2.7M; range $111K to $4.7M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| SYSMEX AMERICA, INC | 2 | $2.8M | Oct 1, 2026 |
| BIOFIRE DEFENSE LLC | 1 | $4.7M | Apr 8, 2026 |
Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Notices whose amount is a placeholder such as $999,999,999 are not added in. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.
- Oct 1, 2026SYSMEX AMERICA, INC$2.7MFY26 Lab Consolidation for Coagulation CPRR EffortNo listed company matched (Materiality N/A)
- Apr 8, 2026BIOFIRE DEFENSE LLC$4.7MBIOFIRE MOLECULAR ANALYZER AT NHCPNo listed company matched (Materiality N/A)
- Dec 9, 2025SYSMEX AMERICA, INC$111KSole Source - Hematology Analyzer, JBPHHNo listed company matched (Materiality N/A)
Competitive landscape
For the 2 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 1 of these past winners lobbied Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff since 2024 (9 filings)
- 0 of their lobbyists list a past Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 32 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 0 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.